Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia
Launched by LYDA OSORIO · Aug 20, 2019
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
Eligibility criteria
- Inclusion Criteria:
- • Fever of less than 15 days
- Exclusion Criteria:
- • Origin of fever identified
About Lyda Osorio
Lyda Osorio is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative studies. With a focus on ethical practices and regulatory compliance, Lyda Osorio collaborates with leading research institutions and healthcare professionals to design and implement high-quality clinical trials. Their mission is to bring safe and effective therapies to market by rigorously evaluating new treatments and ensuring robust data collection and analysis. With a patient-centric approach, Lyda Osorio aims to contribute significantly to the fields of medicine and healthcare, ultimately improving outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yopal, Casanare, Colombia
Piedecuesta, Santander, Colombia
Cali, Valle Del Cauca, Colombia
Patients applied
Trial Officials
Lyda Osorio, MD PhD
Principal Investigator
Universidad del Valle
Diana Ma Caicedo, MD MSc
Principal Investigator
Universidad del Valle
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials